Lina Han
Hebei Medical University(CN)Ningbo No. 2 Hospital(CN)Fourth Hospital of Hebei Medical University(CN)Ningbo No.6 Hospital(CN)The University of Texas Southwestern Medical Center(US)The University of Texas Southwestern Medical Center(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Protein Degradation and Inhibitors, Histone Deacetylase Inhibitors Research, Multiple Myeloma Research and Treatments, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → An inhibitor of oxidative phosphorylation exploits cancer vulnerability(2018)924 cited
- → Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia(2013)726 cited
- → 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party(2021)681 cited
- → Repression of BMI1 in normal and leukemic human CD34+ cells impairs self-renewal and induces apoptosis(2009)177 cited
- → Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia(2022)173 cited
- → Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models(2019)113 cited